Production —
Training activity: 8

Details

Audit the process for material release and make recommendations for actions including:

• Starting materials
• Packaging components

Type

Developmental training activity (DTA)

Evidence requirements

Evidence the activity has been undertaken by the trainee​.

Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.

An action plan to implement learning and/or to address skills or knowledge gaps identified.

Considerations

• Regulatory and good practice guidance
• Current processes and potential impact on patient safety
• Regulatory framework
• Potential impact of OOS or deviation on acceptability and patient safety
• Pharmaceutical quality system
• Documentation
• Training needs
• Physical release process
• Decision making process

Reflective practice guidance

The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.

Before action

• What criteria will you use to assess the effectiveness of the material release process and to formulate your recommendations?
• What specific understanding do you hope to gain about the critical steps and considerations in the process of releasing starting materials and packaging components for use in pharmaceutical production?
• How do you expect this activity will enhance your ability to apply the principles of supplier approval and quality assessment in a practical auditing context?
• What insights might you gain into the role of auditing in ensuring the quality and compliance of incoming materials?
• Discuss with your training officer the current process for material release, including relevant standard operating procedures (SOPs) and quality control checks.
• Review the principles of auditing and consider what constitutes a robust material release process.
• Familiarise yourself with the specifications and quality requirements for starting materials and packaging components used in the department.

In action

• Pay attention to your actions while auditing the material release process.
  • How are you approaching the audit for starting materials and packaging components?
  • Why are you doing it this way? What decisions are you making as you examine the procedures and records for material release? For example, how are you determining compliance with established standards?
• How effective are your actions in identifying strengths and weaknesses in the material release process?
  • What challenges are you facing as you review documentation and potentially observe the release procedures?
  • What can you learn from the process of conducting this audit as it unfolds? For instance, are you gaining a better understanding of the critical quality attributes of starting materials and packaging components?
  • How does this activity connect to your understanding of supplier approval and quality assessment?
• Are there alternative audit techniques you could be considering? For example, are you focusing on documentation review or process observation?
  • What support or guidance might you need in the moment if you identify a potential critical non-compliance or are unsure about the interpretation of a requirement?
  • Are you ensuring your recommendations for action are focused on maintaining the quality of materials used in pharmaceutical production?

On action

• What were the key steps in the process for releasing starting materials and packaging components?
  • What criteria and checks were in place for quality assessment before release?
  • What documentation was reviewed as part of the audit?
  • Were there clear roles and responsibilities defined for material release?
  • What strengths and weaknesses did you identify in the material release process?
  • What recommendations did you make for improvement
• What did you learn about the importance of robust material release processes in ensuring the quality of pharmaceutical products?
  • What are the key quality attributes that need to be assessed for starting materials and packaging components before release?
  • How does the material release process contribute to good manufacturing practice (GMP)?
  • What are the potential consequences of inadequate material release procedures?
• How will you approach auditing material release processes in the future?
  • What key questions will you ask and what documentation will you focus on during such audits?
  • How will this learning contribute to your understanding of quality assurance principles in pharmaceutical manufacturing?

Beyond action

• Have you reviewed your audit of the material release process and the recommendations you made in light of subsequent experiences with quality audits or your increasing understanding of supplier approval and quality assessment?
  • Has your understanding of the criticality of starting materials and packaging components to the quality of finished pharmaceutical products evolved since this training activity?
  • Have you participated in or observed other audit processes that have given you new perspectives on auditing material release?
• Has this training activity enhanced your understanding of the importance of quality assurance in the supply chain and the role of audits in ensuring compliance?
  • How has the process of conducting an audit and making recommendations influenced your critical thinking and problem-solving skills in other situations?
  • Have you applied your understanding of GMP and quality management systems in other areas of your training?
• How will your experience in auditing material release processes contribute to your future role in quality assurance, regulatory affairs, or supplier management?
  • What skills, such as attention to detail, analytical thinking, and the ability to identify areas for improvement, did you develop through this activity that will be valuable in your future practice?
  • What further learning or experience in auditing techniques, quality risk management, and supplier quality would enhance your professional development?

Relevant learning outcomes

#	Outcome
# 1	Outcome Describe the working practices of pharmaceutical production.
# 3	Outcome Perform a range of manufacturing activities, using specialist equipment, in accordance with requirements for GMP and pharmaceutical quality management systems.
# 4	Outcome Apply the principles of supplier approval and quality assessment to evaluate a range of starting materials and packaging components.
# 6	Outcome Apply the principles of quality risk management to the manufacturing process.